Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
Crossref DOI link: https://doi.org/10.1007/s12325-020-01583-9
Published Online: 2021-02-04
Published Print: 2021-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Stein, Dan J.
Khoo, Jon-Paul
Picarel-Blanchot, Françoise
Olivier, Valérie
Van Ameringen, Michael
Funding for this research was provided by:
Servier
Text and Data Mining valid from 2021-02-04
Version of Record valid from 2021-02-04
Article History
Received: 14 September 2020
Accepted: 19 November 2020
First Online: 4 February 2021